84-1221-64 CHD7 (Chromodomain-helicase-DNA-binding Protein 7, CHD-7, ATP-dependent Helicase CHD7, KIAA1416) 100ug C3880-51C
特徴
- Human CHD7 is a chromodomain helicase DNA-binding protein and mutations in the CHD7 gene are a major cause of CHARGE syndrome.
- CHARGE syndrome is a well characterized multiple-malformation syndrome with distinctive diagnostic critera.
- Anomalies include ocular coloboma, choanal atresia, cranial nerve defects, distinctive external and inner ear abnormalities, hearing loss, cardiovascular malformations, urogenital anomalies, and growth retardation.
- Applications:Suitable for use in ELISA.
- Other applications not tested.
- Recommended Dilution:ELISA: 1:64,000Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for at least 12 months.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size：100ug
- Host：goat
- Source Antibody：human
- Grade：Affinity Purified
- Purity：Purified by immunoaffinity chromatography.
- Form：Supplied as a liquid in Tris saline, 0.02% sodium azide, pH 7.3, 0.5% BSA.
- Specificity：Recognizes CHD7. Species sequence homology: Human, mouse and rat.
- Isotype：IgG
- Calc Applications Abbrev：E
- Calc Crossreactivity：Hu Mo Rt
- Immunogen：Synthetic peptide corresponding to C-KDEIDEFANSPSE, from CHD7, at the internal region of the protein sequence (NP_060250.2).
- Shelf Life：1year
- EU Commodity Code：30021010
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
